When science meets purpose — and women lead the way. The RosalindTest is not just a diagnostic tool. It’s the outcome of years of research, driven by a vision: to make early breast cancer detection more accessible, non-invasive, and centered on women’s realities. Clinically validated and published by Scientific Reports, a journal from the Nature group, this test went through a rigorous process — in its clinical validation. At the Sthorm Festival 2024, we hosted a special conversation between presenter Titi Müller and the scientists behind the test, Dr. Beatriz and Dr. Glaucia, sharing the human side of this scientific journey. Women talking to women about science, trust, and care. What we witnessed wasn’t just a product reveal. It was a reminder: when science listens, when it’s co-created with empathy, it becomes transformative. Proud to support initiatives like this. Created by LiqSci | Powered by Sthorm Learn more: rosalindtest.com.br #Sthorm #RosalindTest #ScienceWithPurpose #WomenInScience #LiquidBiopsy #EarlyDetection #HealthInnovation #DeepTech #FutureOfHealthcare
